Gorjan Hrustanovic, Ph.D.
Dr. Hrustanovic is Principal at BVF Partners L.P., joining their organization in 2015, and serves on the board of Rain Therapeutics, Inc.
Prior to joining the BVF Partners L.P., Dr. Hrustanovic obtained his Ph.D. in Cancer Biology & Cell Signaling at the University of California, San Francisco (UCSF), where he also co-founded a small biotech-focused investment fund. At UCSF, his research focus was personalized medicine and molecularly targeted therapy in non-small cell lung cancer. His research in cancer biology is published in peer-reviewed journals such as Nature Medicine, Cell Reports, Nature Genetics, and Oncogene. He holds a B.S. degree in Molecular Biology, and a B.S. in Economics/Management Science from UCSD.